Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 61


Geraniin inhibits oral cancer cell migration by suppressing matrix metalloproteinase-2 activation through the FAK/Src and ERK pathways.

Yeh CM, Hsieh MJ, Yang JS, Yang SF, Chuang YT, Su SC, Liang MY, Chen MK, Lin CW.

Environ Toxicol. 2019 Jun 11. doi: 10.1002/tox.22809. [Epub ahead of print]


The potential utility of melatonin in the treatment of childhood cancer.

Chao YH, Wu KH, Yeh CM, Su SC, Reiter RJ, Yang SF.

J Cell Physiol. 2019 Apr 3. doi: 10.1002/jcp.28566. [Epub ahead of print] Review.


Hypersensitivity and Cardiovascular Risks Related to Allopurinol and Febuxostat Therapy in Asians: A Population-Based Cohort Study and Meta-Analysis.

Chen CH, Chen CB, Chang CJ, Lin YJ, Wang CW, Chi CC, Lu CW, Chen WT, Pan RY, Su SC, Hsu LA, Chang YC, Yu KH, Wu YJ, Lin KM, Hung SI, Chen SM, Chung WH.

Clin Pharmacol Ther. 2019 Jan 28. doi: 10.1002/cpt.1377. [Epub ahead of print]


HLA Alleles and CYP2C9*3 as Predictors of Phenytoin Hypersensitivity in East Asians.

Su SC, Chen CB, Chang WC, Wang CW, Fan WL, Lu LY, Nakamura R, Saito Y, Ueta M, Kinoshita S, Sukasem C, Yampayon K, Kijsanayotin P, Nakkam N, Saksit N, Tassaneeyakul W, Aihara M, Lin YJ, Chang CJ, Wu T, Hung SI, Chung WH.

Clin Pharmacol Ther. 2019 Feb;105(2):476-485. doi: 10.1002/cpt.1190. Epub 2018 Sep 30.


Melatonin Sensitizes Hepatocellular Carcinoma Cells to Chemotherapy Through Long Non-Coding RNA RAD51-AS1-Mediated Suppression of DNA Repair.

Chen CC, Chen CY, Wang SH, Yeh CT, Su SC, Ueng SH, Chuang WY, Hsueh C, Wang TH.

Cancers (Basel). 2018 Sep 10;10(9). pii: E320. doi: 10.3390/cancers10090320.


Severe cutaneous adverse reactions induced by targeted anticancer therapies and immunotherapies.

Chen CB, Wu MY, Ng CY, Lu CW, Wu J, Kao PH, Yang CK, Peng MT, Huang CY, Chang WC, Hui RC, Yang CH, Yang SF, Chung WH, Su SC.

Cancer Manag Res. 2018 May 17;10:1259-1273. doi: 10.2147/CMAR.S163391. eCollection 2018. Review.


Melatonin attenuates osteosarcoma cell invasion by suppression of C-C motif chemokine ligand 24 through inhibition of the c-Jun N-terminal kinase pathway.

Lu KH, Su SC, Lin CW, Hsieh YH, Lin YC, Chien MH, Reiter RJ, Yang SF.

J Pineal Res. 2018 Oct;65(3):e12507. doi: 10.1111/jpi.12507. Epub 2018 May 28.


Functional Interaction between Melatonin Signaling and Noncoding RNAs.

Su SC, Reiter RJ, Hsiao HY, Chung WH, Yang SF.

Trends Endocrinol Metab. 2018 Jun;29(6):435-445. doi: 10.1016/j.tem.2018.03.008. Epub 2018 Apr 6. Review.


The Medication Risk of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Asians: The Major Drug Causality and Comparison With the US FDA Label.

Wang YH, Chen CB, Tassaneeyakul W, Saito Y, Aihara M, Choon SE, Lee HY, Chang MM, Roa FD, Wu CW, Zhang J, Nakkam N, Konyoung P, Okamoto-Uchida Y, Cheung CM, Huang JW, Ji C, Cheng B, Hui RC, Chu CY, Chen YJ, Wu CY, Hsu CK, Chiu TM, Huang YH, Lu CW, Yang CY, Lin YT, Chi MH, Ho HC, Lin JY, Yang CH, Chang YC, Su SC, Wang CW, Fan WL, Hung SI, Chung WH; Asian Severe Cutaneous Adverse Reaction Consortium.

Clin Pharmacol Ther. 2019 Jan;105(1):112-120. doi: 10.1002/cpt.1071. Epub 2018 Aug 9.


Phytochemicals in Skin Cancer Prevention and Treatment: An Updated Review.

Ng CY, Yen H, Hsiao HY, Su SC.

Int J Mol Sci. 2018 Mar 22;19(4). pii: E941. doi: 10.3390/ijms19040941. Review.


The Function of HLA-B*13:01 Involved in the Pathomechanism of Dapsone-Induced Severe Cutaneous Adverse Reactions.

Chen WT, Wang CW, Lu CW, Chen CB, Lee HE, Hung SI, Choon SE, Yang CH, Liu MT, Chen TJ, Fan WL, Su SC, Lin YY, Chang YC, Chung WH; Taiwan Severe Cutaneous Adverse Reaction Consortium.

J Invest Dermatol. 2018 Jul;138(7):1546-1554. doi: 10.1016/j.jid.2018.02.004. Epub 2018 Feb 17.


Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions.

Wang CW, Yang LY, Chen CB, Ho HC, Hung SI, Yang CH, Chang CJ, Su SC, Hui RC, Chin SW, Huang LF, Lin YY, Chang WY, Fan WL, Yang CY, Ho JC, Chang YC, Lu CW, Chung WH; the Taiwan Severe Cutaneous Adverse Reaction (TSCAR) Consortium.

J Clin Invest. 2018 Mar 1;128(3):985-996. doi: 10.1172/JCI93349. Epub 2018 Feb 5.


Compositional and functional variations of oral microbiota associated with the mutational changes in oral cancer.

Yang SF, Huang HD, Fan WL, Jong YJ, Chen MK, Huang CN, Chuang CY, Kuo YL, Chung WH, Su SC.

Oral Oncol. 2018 Feb;77:1-8. doi: 10.1016/j.oraloncology.2017.12.005. Epub 2017 Dec 9.


HLA Association with Drug-Induced Adverse Reactions.

Fan WL, Shiao MS, Hui RC, Su SC, Wang CW, Chang YC, Chung WH.

J Immunol Res. 2017;2017:3186328. doi: 10.1155/2017/3186328. Epub 2017 Nov 23. Review.


Melatonin as a potential inhibitory agent in head and neck cancer.

Yeh CM, Su SC, Lin CW, Yang WE, Chien MH, Reiter RJ, Yang SF.

Oncotarget. 2017 Aug 9;8(52):90545-90556. doi: 10.18632/oncotarget.20079. eCollection 2017 Oct 27. Review.


Association of melatonin membrane receptor 1A/1B gene polymorphisms with the occurrence and metastasis of hepatocellular carcinoma.

Su SC, Ho YC, Liu YF, Reiter RJ, Chou CH, Yeh CM, Lee HL, Chung WH, Hsieh MJ, Yang SF.

Oncotarget. 2017 Sep 20;8(49):85655-85669. doi: 10.18632/oncotarget.21107. eCollection 2017 Oct 17.


Melatonin suppresses hepatocellular carcinoma progression via lncRNA-CPS1-IT-mediated HIF-1α inactivation.

Wang TH, Wu CH, Yeh CT, Su SC, Hsia SM, Liang KH, Chen CC, Hsueh C, Chen CY.

Oncotarget. 2017 Jul 18;8(47):82280-82293. doi: 10.18632/oncotarget.19316. eCollection 2017 Oct 10.


Exome Sequencing of Oral Squamous Cell Carcinoma Reveals Molecular Subgroups and Novel Therapeutic Opportunities.

Su SC, Lin CW, Liu YF, Fan WL, Chen MK, Yu CP, Yang WE, Su CW, Chuang CY, Li WH, Chung WH, Yang SF.

Theranostics. 2017 Feb 26;7(5):1088-1099. doi: 10.7150/thno.18551. eCollection 2017.


MMP-11 promoted the oral cancer migration and Fak/Src activation.

Hsin CH, Chou YE, Yang SF, Su SC, Chuang YT, Lin SH, Lin CW.

Oncotarget. 2017 May 16;8(20):32783-32793. doi: 10.18632/oncotarget.15824.


Combinations of SERPINB5 gene polymorphisms and environmental factors are associated with oral cancer risks.

Tsai HT, Hsieh MJ, Lin CW, Su SC, Miao NF, Yang SF, Huang HC, Lai FC, Liu YF.

PLoS One. 2017 Mar 24;12(3):e0163369. doi: 10.1371/journal.pone.0163369. eCollection 2017.

Supplemental Content

Loading ...
Support Center